Allergy and Immunology · Corpus Christi, TX
NPI
1225246747
Since 2007
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6021 Parkway Dr
Corpus Christi, TX, 78414
Phone (361) 985-0323
Groups this clinician bills Medicare through
Medicare paid, 2024
$189K
11,403 services
Medicare patients, 2024
182
Average age 73
Drug cost, 2024
$1.4M
1,196 prescriptions
Company payments, 2025
$21K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adrienne M Tinana was code 95004 (test - miscellaneous), 2,971 times for 48 patients. In total Adrienne M Tinana billed 11,403 services in 29 codes, and Medicare paid $189K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 2,971 | 48 | $2.54 | $7,537 |
| 95044 Test - Miscellaneous | Office | 861 | 12 | $2.85 | $2,451 |
| 95165 Treatment - Miscellaneous | Office | 360 | 18 | $10.29 | $3,703 |
| 96372 Injection Administration | Office | 255 | 18 | $9.55 | $2,436 |
| 95024 Test - Miscellaneous | Office | 238 | 21 | $5.66 | $1,347 |
| 95117 Treatment - Miscellaneous | Office | 191 | 18 | $7.31 | $1,396 |
| 99213 Office E&M - Established | Office | 104 | 78 | $58.18 | $6,051 |
| 99204 Office E&M - New | Office | 73 | 72 | $103.51 | $7,556 |
| 99214 Office E&M - Established | Office | 64 | 52 | $84.40 | $5,402 |
| 95012 Pulmonary | Office | 37 | 29 | $11.98 | $443 |
| 94010 Pulmonary Function Testing | Office | 32 | 28 | $17.12 | $548 |
| 99212 Office E&M - Established | Office | 15 | 13 | $40.82 | $612 |
By year: 2022 $138K for 6,888 services; 2023 $135K for 8,538 services; 2024 $189K for 11,403 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adrienne M Tinana prescribed most often to Medicare patients was Levocetirizine Dihydrochloride, with 154 prescriptions and refills. In total Adrienne M Tinana wrote 1,196 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride Generic | 154 | 331 | 46 | $1,746 |
| Azelastine Hcl Generic | 108 | 173 | 52 | $3,216 |
| Fluticasone Propionate Generic | 82 | 154 | 32 | $1,370 |
| Cuvitru Immun Glob G(Igg)/Gly/Iga Ov50 | 73 | 73 | Under 11 | $507K |
| Xolair Omalizumab | 63 | 63 | Under 11 | $182K |
| Montelukast Sodium Generic | 61 | 142 | 17 | $836 |
| Ipratropium Bromide Generic | 55 | 68 | 12 | $1,923 |
| Epinephrine Generic | 53 | 53 | 51 | $11K |
| Prednisone Generic | 38 | 38 | 30 | $72.18 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 32 | 32 | Under 11 | $261K |
| Azelastine-Fluticasone Azelastine/Fluticasone | 28 | 39 | Under 11 | $3,688 |
| Famotidine Generic | 28 | 58 | Under 11 | $516 |
| Advair Hfa Fluticasone Propion/Salmeterol | 27 | 30 | Under 11 | $8,931 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 26 | 28 | Under 11 | $18K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 25 | 47 | Under 11 | $4,385 |
Brand drugs: 455 claims; generic drugs: 741 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adrienne M Tinana $21K ($21K in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $20K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 35 | $20K |
| Galderma Laboratories, L.P. GALD.SW | 13 | $249 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $194 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $147 |
| Melinta Therapeutics, LLC | 1 | $122 |
| Verona Pharma, Inc. VRNA | 1 | $117 |
| Genzyme Corporation SNY | 2 | $77.82 |
| GlaxoSmithKline, LLC. GSK | 3 | $53.97 |
| Amgen Inc. AMGN | 2 | $52.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.